Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Ariosa Diagnostics, Inc. v. Illumina, Inc.
Case Number:
16-2388
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
March 13, 2018
Illumina Tells Fed. Circ. Ariosa Doesn't Deserve 2nd Chance
Illumina Inc. urged the Federal Circuit to pass on Ariosa Diagnostics Inc.'s bid for a rehearing of an affirmed Patent Trial and Appeal Board decision in the companies' long-running feud over prenatal testing technology, arguing there was nothing "exceptionally important" about the panel's ruling.
-
February 27, 2018
Full Fed. Circ. Urged To Rethink Illumina Patent Challenge
The Electronic Frontier Foundation has thrown its support behind Ariosa Diagnostics Inc.'s request for a full Federal Circuit rehearing of an affirmed Patent Trial and Appeal Board decision the nonprofit argues is contrary to both the Patent Act and public policy.
-
December 11, 2017
Fed. Circ. Says It Can't Review PTAB Re-Exam Terminations
The Federal Circuit on Monday said it does not have the power to review Patent Trial and Appeal Board decisions to terminate patent re-examinations in a short order refusing to revive a challenge to an Illumina Inc. diagnostic patent.